Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
Launched by GUOHUA ZENG · Oct 22, 2018
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
Retrograde intrarenal surgery (RIRS) has been considered as the first-line choice for the management of \<20mm kidney stones. Insertion of a ureteral access sheath (UAS) before RIRS surgery is currently accepted as an effective method to improve the effectiveness of surgery, but can be accompanied by serious complications. In long-term clinical practice, the investigators has found that many ureteral injuries occur during UAS insertion of the ureter from ureteral orifice. And if we use rigid ureteroscopy to insert the UAS under direct vision, we can provide the UAS insertion success rate an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients must be a suitable operative candidate for RIRS
- • 2. Age 18 to 70 years
- • 3. Normal renal function 4 .ASA score Ⅰ and Ⅱ
- • 5. Single renal stone ≤20mm or multiple stones the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) up to 20 mm
- Exclusion Criteria:
- • 1. Patients with solitary kidney
- • 2. Uncorrected coagulopathy and active urinary tract infection (UTI)
- • 3. Prior ipsilateral endourological procedure history, such as RIRS, PCNL, URS and URL
- • 4. Patients who underwent transplant or urinary diversion.
- • 5. Congenital abnormalities.
About Guohua Zeng
Guohua Zeng is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and rigorous scientific methodologies. With a focus on enhancing therapeutic options across various medical fields, Guohua Zeng collaborates with leading researchers and healthcare professionals to ensure the highest standards of safety and efficacy in clinical studies. The sponsor is driven by a mission to translate pioneering research into tangible health solutions, fostering an environment of collaboration, integrity, and excellence in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Guohua Zeng, Ph.D and M.D
Study Chair
The First Affiliated Hospital of Guangzhou Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials